Recurrent ovarian cancer may reoperation
Immunotherapy for recurrent ovarian cancer may extend the survival time of patients Wagner, the German pair of recurrence of ovarian cancer a mouse monoclonal anti-idiotypic antibody immune ACA125 consolidation therapy (tumo...
Recurrent ovarian cancer chemotherapy new method - conventional chemotherapy drug efficacy forecast molecular targeted chemotherapy Ovarian cancer is the worst prognosis of gynecologic tumors. Patients with advanced epithelial ovarian cancer five-year survival rates gene...
Health, will be right recurrent ovarian cancer surgery and chemotherapy again whether there has been significant controversy. Fourth Military Medical University Xijing Hospital director of obstetrics and gynecology professor Detang, has nearly 10 years of the 38 treated patients with recurrent epithelial ovarian cancer clinical data were analyzed retrospectively after that, again recurrent ovarian cancer surgery and chemotherapy, can further improve the survival rate of patients.
Primary ovarian tumors, 60.0% to 90.0% of epithelial cancer, the initial clinical surgery after chemotherapy to cure, but there is still 85.0% of cases in the near and long-term recurrence. These 38 patients with recurrent ovarian cancer, 20 patients underwent laparotomy again recurrence cytoreductive surgery, nine cases due to fear of surgery and chemotherapy alone by the other nine cases by the Chinese or abandon treatment. Results showed that 20 cases of reoperation after 2 ~ 5-year survival rates were 69.8%, 52.4%, 42.7% and 26.4%; 9 patients receiving chemotherapy alone 2 to 5 year survival rates were 68.9%, 13 .8%, 8.7% and 6.9%, surgery and chemotherapy alone again five-year survival rate is significantly different (P <0.01); nine cases using Chinese medicine for cancer or abandon the 2 to 5 year survival rates were 29.4% , 18.9%, 16.8% and 2.9%, and another surgery five-year survival rate, the difference is significant
Experience with ovarian cancer Treatment of ovarian cancer is still surgery and chemotherapy, although postoperative adjuvant systemic chemotherapy has been the effect cer...
Complete remission after isolation of patients with recurrent ovarian cancer viable again cytoreductive surgery Denmark Gronloud such report, as paclitaxel plus platinum chemotherapy after complete remission in patients with ovarian cancer, if recurren...
Previous accept carboplatin multidrug chemotherapy in patients with recurrent ovarian cancer Carboplatin and Paclitaxel weekly therapy is safe and effective Kikuchi, the Japanese report, have received platinum multidrug chemotherapy for recurrent ovarian cancer Japanese women, a weekly carboplati...
Ovarian cancer treatment A benign ovarian tumors young patients affected Annex tumor resection or stripped of. If both bilateral ovarian tumors, should fight to reta...
P53 gene can cure ovarian cancer Abstract: a group P53 mutations in the genes in patients with advanced ovarian cancer by more cycles of P53 gene therapy and chemotherapy, r...
Ovarian cancer on the related knowledge Ovarian cancer in gynecologic tumors are the highest level of a vicious, high extensive abdominal and pelvic metastasis. If the surgery for...
Ovarian cancer screening, treatment and prevention of the Current Situation and Prospect
Tags: cancer, cases, chemotherapy, clinical, early, eat, ovarian, patients, rate, surgery, survival, therapy, treatment, tumor, tumors